Public policies blocked many families of Mexican descent living in the U.S. from accessing vital services such as food and mental health care during the COVID-19 pandemic, even though these communities experienced some of the highest infection and mortality rates.
Eisai eyes long game for Leqembi amid ‘dramatically’ increasing patient use
Full US approval of Biogen and Eisai’s Alzheimer’s drug Leqembi — and as a result, broad Medicare coverage — has led to a surge in
November 8, 2023